| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |